SEROPRAM 20 mg/0.5 ml, concentrate for solution for infusion 10 ampoules of 0.5 ml
Active ingredients: Citalopram hydrochloride, CITALOPRAM BASE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion10 ampoules of 0.5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SEROPRAM 20 mg/0,5 ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 0,5 ml
- Marketing authorisation holder
- LUNDBECK SAS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 1998
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69901965CIP75615580CIP133400956155804Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE CITALOPRAMsolution | 22,24 mg · une ampoule | SA |
| CITALOPRAM BASEsolution | 20 mg · une ampoule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.